- Home
- RYTM vs NMAX Comparison
RYTM vs NMAX Comparison
Compare RYTM & NMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- NMAX
- Stock Information
- Founded
- RYTM 2008
- NMAX 1998
- Country
- RYTM United States
- NMAX United States
- Employees
- RYTM N/A
- NMAX N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- NMAX
- Sector
- RYTM Health Care
- NMAX
- Exchange
- RYTM Nasdaq
- NMAX NYSE
- Market Cap
- RYTM 3.8B
- NMAX 3.3B
- IPO Year
- RYTM 2017
- NMAX 2025
- Fundamental
- Price
- RYTM $61.74
- NMAX $25.50
- Analyst Decision
- RYTM Strong Buy
- NMAX
- Analyst Count
- RYTM 12
- NMAX 0
- Target Price
- RYTM $74.92
- NMAX N/A
- AVG Volume (30 Days)
- RYTM 940.6K
- NMAX 5.9M
- Earning Date
- RYTM 05-06-2025
- NMAX 01-01-0001
- Dividend Yield
- RYTM N/A
- NMAX N/A
- EPS Growth
- RYTM N/A
- NMAX N/A
- EPS
- RYTM N/A
- NMAX N/A
- Revenue
- RYTM $130,126,000.00
- NMAX $171,016,455.00
- Revenue This Year
- RYTM $43.84
- NMAX N/A
- Revenue Next Year
- RYTM $65.62
- NMAX N/A
- P/E Ratio
- RYTM N/A
- NMAX N/A
- Revenue Growth
- RYTM 68.06
- NMAX 26.42
- 52 Week Low
- RYTM $35.17
- NMAX $14.00
- 52 Week High
- RYTM $68.58
- NMAX $265.00
- Technical
- Relative Strength Index (RSI)
- RYTM 61.94
- NMAX N/A
- Support Level
- RYTM $59.54
- NMAX N/A
- Resistance Level
- RYTM $62.83
- NMAX N/A
- Average True Range (ATR)
- RYTM 4.27
- NMAX 0.00
- MACD
- RYTM 1.00
- NMAX 0.00
- Stochastic Oscillator
- RYTM 92.04
- NMAX 0.00
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About NMAX NEWSMAX INC
Newsmax Inc is a multi-platform media company. The company provides original news and lifestyle updates from its linear cable television and over-the-top (OTT) news channels, websites, proprietary database, publishing products, and e-commerce products. The Company uses original news and editorial content to draw large numbers of readers to its media outlets to sell advertising, print, and online information products. The Company's business operations are conducted through two operating segments, Broadcasting and Digital. The company generates maximum revenue from the Broadcasting Segment.